← Leaderboards
Ghadeer K. Dawwas
University Of Pennsylvania
$930,886
Attributed
$930,886
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2021–25$250K$187.5K$125K$62.5K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$930,886 · 2
By mechanism
R00$747,000 · 1
K99$183,886 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Mortimer Poncz$48,626,684
- Vladimir R Muzykantov$31,969,177
- Stephen E. Kimmel$22,183,706
- Sean P Hennessy$26,496,214
- Garret A Fitzgerald$242,218,424
Others in their field
Other Emerging Leaders on “Acute”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$51,003,204
- Julie Ake · National Institute Of Allergy And Infectious Diseases$41,692,120
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
Research focus
AcuteAffectAlternative TreatmentAdherenceAmerican Heart AssociationAnticoagulantsAppropriate DoseAttentionAwardAmericanBenefits And RisksBiometryCareer DevelopmentCharacteristicsComparative EffectivenessComparative SafetyCrohn&AposDatabasesData LinkagesDesignDiagnosisDisciplineDisorder SubtypeEffectiveness
Grant awards (5)
Anticoagulant use, safety, and effectiveness for venous thromboembolism prevention in inflammatory bowel disease patients$249,000
R00 · FY2025 · HL · contact PI
Anticoagulant use, safety, and effectiveness for venous thromboembolism prevention in inflammatory bowel disease patients$249,000
R00 · FY2024 · HL · contact PI
Anticoagulant use, safety, and effectiveness for venous thromboembolism prevention in inflammatory bowel disease patients$249,000
R00 · FY2023 · HL · contact PI
Anticoagulant use, safety, and effectiveness for venous thromboembolism prevention in inflammatory bowel disease patients$91,943
K99 · FY2022 · HL · contact PI
Anticoagulant use, safety, and effectiveness for venous thromboembolism prevention in inflammatory bowel disease patients$91,943
K99 · FY2021 · HL · contact PI